Mitogen-activated protein kinase (MAPK) and Wnt signaling pathways are critical for melanocyte development and melanogenesis and could be novel therapeutic targets for modulating melanin synthesis. Ligustroside is a derivative of secoiridoid compounds and has antiviral, mitochondrial dysfunction improving, and antioxidant effects. The present study aimed to evaluate the anti-melanogenesis effect of ligustroside on α-MSH-induced B16F10 murine melanoma cells.
The cytotoxicity of ligustroside was tested
via MTT assay. Furthermore, the effects of ligustroside on the expression of critical melanogenic markers such as tyrosinase, tyrosinase related proteins (TRPs), and microphthalmia-associated transcription factor (MITF) were analyzed at both mRNA and protein levels
via RT-qPCR and Western blot, respectively, in α-melanocyte stimulating hormone-induced B16F10 cells. In addition, phosphorylation of p38, ERK and JNK proteins was investigated. Immunofluorescence analysis of MITF was also conducted.
Ligustroside significantly reduced intracellular tyrosinase activity and melanin content by 37.11% and 29.12%, respectively, compared to untreated cells. Moreover, it downregulated the expression of MITF, tyrosinase, TRP-1, and TRP-2 at the mRNA and protein levels by regulating both the MAPK and protein kinase A (PKA)/cAMP response element-binding protein (CREB) signaling pathways. Ligustroside also suppressed the nuclear protein expression of MITF, β-catenin, and p-CREB, and decreased immunofluorescence intensity of nuclear MITF.
Ligustroside derived from
Ligustrum japonicum shows a significant anti-melanogenesis effect
via suppression of the MAPK and PKA/CREB signaling pathways.
The work entitled “
Ligustroside derived from Ligustrum japonicum inhibits melanogenesis via blocking the MAPK and PKA/CREB signaling pathways” was published on
Asian Pacific Journal of Tropical Biomedicine (published on Jan. 17, 2025).
DOI:
10.4103/apjtb.apjtb_568_24